SCHEMBL9809488

SCHEMBL9809488

CC(=O)[C@](O[Si](C)(C)C)(c1ccccc1)C1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.46
NFE2L2 Q16236 1/20 0.46
POLB P06746 1/20 0.41
CHRM3 P20309 12/20 0.41
CHRM2 P08172 8/20 0.41
CHRM1 P11229 7/20 0.41
CHRM4 P08173 5/20 0.41
ALDH1A1 P00352 1/20 0.40
KCNH2 Q12809 3/20 0.40
SLC6A3 Q01959 1/20 0.40
KIF11 P52732 1/20 0.39
HRH1 P35367 2/20 0.39
SLC29A1 Q99808 1/20 0.39
CHRM5 P08912 1/20 0.39
HTR2B P41595 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9809468 1.00 KEAP1 (0.46) KEAP1NFE2L2POLBCHRM3CHRM2
SCHEMBL9618869 0.82 KEAP1 (0.49) KEAP1NFE2L2POLBCHRM3CHRM2
SCHEMBL9809517 0.81 KEAP1 (0.38) KEAP1NFE2L2POLBCHRM3CHRM2
SCHEMBL4883114 0.80 KEAP1 (0.50) KEAP1NFE2L2POLBCHRM3CHRM2
SCHEMBL5948356 0.78 SSTR4 (0.40) KEAP1NFE2L2
SCHEMBL5948488 0.78 SSTR4 (0.40) KEAP1NFE2L2
SCHEMBL2763726 0.75 KEAP1 (0.56) KEAP1NFE2L2POLBCHRM3CHRM2
SCHEMBL13865471 0.74 KEAP1 (0.54) KEAP1NFE2L2POLBCHRM3CHRM2
SCHEMBL17739911 0.74 KEAP1 (0.54) KEAP1NFE2L2POLBCHRM3CHRM2
SCHEMBL9809511 0.73 KEAP1 (0.72) KEAP1NFE2L2POLBCHRM3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5036107-A Treatment of neurogenic bladder disorders MARION MERRELL DOW INC. (US) 1991-07-30 US disclosed